​

Globus Medical (GMED) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

GMED Stock Forecast

Globus Medical (GMED) stock forecast, based on 36 Wall Street analysts, predicts a 12-month average price target of $89.67, with a high of $105.00 and a low of $64.00. This represents a 3.21% increase from the last price of $86.88.

$45 $57 $69 $81 $93 $105 High: $105 Avg: $89.67 Low: $64 Last Closed Price: $86.88

GMED Stock Rating

Globus Medical stock's rating consensus is Buy, based on 36 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 26 Buy (72.22%), 9 Hold (25.00%), 1 Sell (2.78%), and 0 Strong Sell (0.00%).

Buy
Total 36 1 9 26 Strong Sell Sell Hold Buy Strong Buy

GMED Price Target Upside V Benchmarks

TypeNameUpside
StockGlobus Medical3.21%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks19.83%

Price Target Trends

1M3M12M
# Anlaysts244
Avg Price Target$102.50$89.25$89.25
Last Closing Price$86.88$86.88$86.88
Upside/Downside17.98%2.73%2.73%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 25454--13
Nov, 25437--14
Oct, 25436--13
Sep, 25446--14
Aug, 25446--14
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 17, 2025Shagun SinghRBC Capital$100.00$85.7916.56%15.10%
Dec 17, 2025Caitlin CroninCanaccord Genuity$105.00$85.7922.39%20.86%
Oct 28, 2025Thomas StephanStifel Nicolaus$64.00$63.460.85%-26.34%
Oct 10, 2025RBC Capital$88.00$57.5552.91%1.29%
Dec 02, 2024Kallum TitchmarshMorgan Stanley$100.00$85.5216.93%15.10%
Aug 28, 2024Ryan ZimmermanBTIG$77.00$71.737.35%-11.37%
Aug 07, 2024Vik ChopraWells Fargo$78.00$70.5310.59%-10.22%
Jul 15, 2024Drew RanieriMorgan Stanley$71.00$71.07-0.10%-18.28%
May 29, 2024Ryan ZimmermanBTIG$72.00$65.499.94%-17.13%
May 20, 2024Matt O'BrienPiper Sandler$80.00$64.4024.22%-7.92%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 17, 2025RBC CapitalOutperformOutperformhold
Dec 02, 2025Morgan StanleyOverweightOverweighthold
Nov 07, 2025Bank of America SecuritiesUnderperformBuyupgrade
Jun 10, 2025BarclaysOverweightOverweighthold
Nov 06, 2024NeedhamHoldHoldhold
Nov 06, 2024Bank of America SecuritiesUnderperformUnderperformhold
Oct 08, 2024RBC CapitalOutperformOutperformhold
Aug 28, 2024BTIGBuyBuyhold
Aug 13, 2024BarclaysOverweightOverweighthold
Jul 15, 2024Morgan StanleyEqual-WeightEqual-Weighthold

Financial Forecast

EPS Forecast

$0 $1 $2 $3 $4 $5 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.04$1.48$1.89$1.09$0.76----
Avg Forecast$1.36$2.02$2.03$2.31$2.99$3.43$3.93$4.62$4.89
High Forecast$1.37$2.04$2.04$2.34$3.01$3.56$4.55$4.67$4.94
Low Forecast$1.34$2.00$2.02$2.28$2.92$3.24$3.13$4.58$4.84
Surprise %-23.53%-26.73%-6.90%-52.81%-74.58%----

Revenue Forecast

$500M $1B $2B $2B $3B $4B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$789.04M$958.10M$1.02B$1.57B$2.52B----
Avg Forecast$786.87M$951.95M$1.02B$1.56B$2.51B$2.67B$2.85B$3.06B$3.32B
High Forecast$791.54M$957.61M$1.03B$1.57B$2.53B$2.69B$2.85B$3.06B$3.35B
Low Forecast$780.99M$944.84M$1.02B$1.55B$2.50B$2.66B$2.85B$3.05B$3.30B
Surprise %0.28%0.65%-0.20%0.59%0.51%----

Net Income Forecast

$0 $120M $240M $360M $480M $600M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$102.28M$149.19M$190.17M$122.87M$102.98M----
Avg Forecast$46.18M$118.77M$156.07M$122.87M$339.44M$389.74M$466.32M$529.89M$560.54M
High Forecast$75.19M$142.53M$187.28M$147.45M$344.61M$408.46M$521.58M$534.94M$565.80M
Low Forecast$17.16M$95.02M$124.85M$98.30M$334.27M$371.02M$358.42M$524.83M$555.10M
Surprise %121.51%25.61%21.85%--69.66%----

GMED Forecast FAQ

Is Globus Medical stock a buy?

Globus Medical stock has a consensus rating of Buy, based on 36 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 26 Buy, 9 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Globus Medical is a favorable investment for most analysts.

What is Globus Medical's price target?

Globus Medical's price target, set by 36 Wall Street analysts, averages $89.67 over the next 12 months. The price target range spans from $64 at the low end to $105 at the high end, suggesting a potential 3.21% change from the previous closing price of $86.88.

How does Globus Medical stock forecast compare to its benchmarks?

Globus Medical's stock forecast shows a 3.21% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (19.83%).

What is the breakdown of analyst ratings for Globus Medical over the past three months?

  • December 2025: 30.77% Strong Buy, 38.46% Buy, 30.77% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 28.57% Strong Buy, 21.43% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 30.77% Strong Buy, 23.08% Buy, 46.15% Hold, 0% Sell, 0% Strong Sell.

What is Globus Medical’s EPS forecast?

Globus Medical's average annual EPS forecast for its fiscal year ending in December 2025 is $3.43, marking a 351.32% increase from the reported $0.76 in 2024. Estimates for the following years are $3.93 in 2026, $4.62 in 2027, and $4.89 in 2028.

What is Globus Medical’s revenue forecast?

Globus Medical's average annual revenue forecast for its fiscal year ending in December 2025 is $2.67B, reflecting a 6.04% increase from the reported $2.52B in 2024. The forecast for 2026 is $2.85B, followed by $3.06B for 2027, and $3.32B for 2028.

What is Globus Medical’s net income forecast?

Globus Medical's net income forecast for the fiscal year ending in December 2025 stands at $389.74M, representing an 278.45% increase from the reported $102.98M in 2024. Projections indicate $466.32M in 2026, $529.89M in 2027, and $560.54M in 2028.